You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 133 No. 3, March 1997 TABLE OF CONTENTS
  Archives
  •  Online Features
  OBSERVATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (45)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Normal-Mode Ruby Laser for Treating Congenital Nevi

Setsuko Ueda, MD; Shuhei Imayama, MD

Arch Dermatol. 1997;133(3):355-359.


Abstract

Background
Q-switched laser therapy is known to be highly effective in treating dermal melanocytosis and pigmented epidermal lesions. However, to our knowledge, there are no reports on the effectiveness of laser therapy for congenital nevi. We evaluated the clinical efficacy and side effects of normal-mode ruby laser therapy for congenital pigmented lesions containing abundant melanin.

Observations
A normal-mode ruby laser (pulse duration, 0.3-1.0x10-3 seconds; energy fluence, 10-30 J/cm2; and spot size, 10x10 or 15x15 mm) (Toshiba Corp, Tokyo, Japan) was used to treat 3 patients with congenital nevi at intervals of 1 to 4 months. In all 3 cases, the pigmented lesions were significantly reduced almost to the level of the surrounding normal skin after 4 laser treatments. The treated areas were virtually free of scarring, and the skin texture resembled that of the surrounding normal skin. Unsightly hair growth was also reduced.

Conclusions
The normal-mode ruby laser was effective in treating congenital nevi and produced good cosmetic results. The risk of recurrence is unknown, but the 3 patients in our study did not have any recurrences during the 18- to 39-month study period.

Arch Dermatol. 1997;133:355-359



Author Affiliations

From the Ueda-Setsuko Dermatology Clinic (Dr Ueda) and the Department of Dermatology, Faculty of Medicine, Kyushu University (Dr Imayama), Fukuoka, Japan.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

About Moles, Melanomas, and Lasers: The Dermatologist's Schizophrenic Attitude Toward Pigmented Lesions
Dummer
Arch Dermatol 2003;139:1405-1406.
FULL TEXT  

Laser Treatment of Pigmented Lesions-2000: How Far Have We Gone?
Stratigos et al.
Arch Dermatol 2000;136:915-921.
FULL TEXT  

Long- and Short-term Histological Observations of Congenital Nevi Treated With the Normal-Mode Ruby Laser
Imayama and Ueda
Arch Dermatol 1999;135:1211-1218.
ABSTRACT | FULL TEXT  

Treatment of Benign and Atypical Nevi With the Normal-Mode Ruby Laser and the Q-Switched Ruby Laser: Clinical Improvement but Failure to Completely Eliminate Nevomelanocytes
Duke et al.
Arch Dermatol 1999;135:290-296.
ABSTRACT | FULL TEXT  

Long-Pulse Ruby Laser Therapy for Congenital Nevi
Journal Watch Dermatology 1997;1997:4-4.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.